Raymond James & Associates’s Aptus Defined Risk ETF DRSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,214
Closed -$342K 4065
2022
Q1
$342K Sell
12,214
-34,177
-74% -$967K ﹤0.01% 3329
2021
Q4
$1.34M Sell
46,391
-7,755
-14% -$226K ﹤0.01% 2437
2021
Q3
$1.55M Buy
54,146
+4,747
+10% +$140K ﹤0.01% 2280
2021
Q2
$1.46M Buy
49,399
+26,405
+115% +$779K ﹤0.01% 2333
2021
Q1
$674K Buy
22,994
+10,584
+85% +$312K ﹤0.01% 2787
2020
Q4
$364K Sell
12,410
-25,874
-68% -$779K ﹤0.01% 3006
2020
Q3
$1.18M Buy
+38,284
New +$1.18M ﹤0.01% 2084

Other funds holding DRSK

Raymond James & Associates's DRSK Position: Q2 2022 in Review

Raymond James & Associates sold out of Aptus Defined Risk ETF (DRSK) in Q2 2022, closing a stake of 12,214 shares — an estimated $342K sold.

Raymond James & Associates first reported a position in DRSK in Q3 2020 and held it in 7 quarters. The position peaked at $1.55M in Q3 2021. 67 funds tracked by Wall St. Rank hold DRSK as of Q2 2022.

  • Raymond James & Associates reported no remaining Aptus Defined Risk ETF position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 12,214 Aptus Defined Risk ETF shares in Q2 2022, an estimated $342K.
  • Raymond James & Associates first reported a position in Aptus Defined Risk ETF in Q3 2020 and held it in 7 quarters.
  • Raymond James & Associates's Aptus Defined Risk ETF position peaked at $1.55M in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Aptus Defined Risk ETF as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.